NIH Public Access
- 作者Field, Tiffany; Diego, Miguel; Hernandez-reif, Maria
- 卷第33卷
- 期第2期
- 文件大小851.75KB
- 发表时间2011
- DOI10.1016/j.infbeh.2009.12.004.Preterm
- 页码115-124
Editorial: Editorial and editorial board changesBen Greenebaum · 2003
Peripatetic: An Editorial Riff || Editorial: “Peripatetic: An Editorial Riff”Robert S. Fogarty · The Antioch Review · 2012
LAS SOCIEDADES DEL ULTIMO PERIODO DE LA HISTORIA ANTIGUA DE AMERICA || COMENTARIO EDITORIAL / EDITORIAL COMMENT / COMMENTAIRE EDITORIAL / COMENTÁRIO EDITORIALRevista de Arqueología Americana · 1995-1993
Editorial board & international editorial advisory board1998
Editorial board & international editorial advisory board1999
Editorial board & international editorial advisory board1999
Editorial board & international editorial advisory board1999
Editorial/Editorial2008
Clinical comparability and European biosimilar regulationsSchellekens, Huub; Moors, Ellen · 2010
How similar do 'biosimilars' need to be?Schellekens, Huub · 2004
Bioequivalence and the immunogenicity of biopharmaceuticalsSchellekens, Huub · 2002
Interchangeability, immunogenicity and biosimilarsEbbers, Hans C; Crow, Stacy A; Vulto, Arnold G; Schellekens, Huub · Nature Biotechnology · 2012
What's in a name?Schellekens, Huub · Nature Biotechnology · 2014
Biosimilars or semi-similars?Schellekens, Huub; Moors, Ellen · Nature Biotechnology · 2015
Biosimilars need comparative clinical dataCasadevall, Nicole; Thorpe, Robin; Schellekens, Huub · Kidney International · 2011